Lurbinectedin in FET-Fused Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Ewing Sarcoma · Desmoplastic Small Round Cell Tumor · Pediatric Cancer · Undifferentiated Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Study coordinator (Leo Mascarenhas, MD) · leo.mascarenhas@cshs.org · 310-423-4423
Contact: Study coordinator (Emilie Douine-Barthelemy) · emilie.douine-barthelemy@cshs.org · 310-967-0692
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Contact: Study coordinator (Jenna Gedminas, MD) · jenna-gedminas@uiowa.edu · 319-353-6393
Contact: Study coordinator (Chris Stamy) · Chris-Stamy@uiowa.edu · 319-356-7875
Contact: Principal Investigator (Jenna Gedminas, MD)
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Steven Dubois, MD) · steven.dubois@dfci.harvard.edu · 617-632-5460
Contact: Study coordinator (Alexandra Sala) · alexandra_sala@dfci.harvard.edu · 857-215-2410
Contact: Principal Investigator (Steven Dubois, MD)
University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Rashmi Chugh, MD) · rashmim@med.umich.edu · 800-865-1125
Contact: Study coordinator (Cancer AnswerLine) · CancerAnswerLine@med.umich.edu · 1-800-865-1125
Contact: Principal Investigator (Rashmi Chugh, MD)
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Julia Glade Bender, MD) · gladebej@mskcc.org · 212-639-6729
Contact: Study coordinator (Robert Maki, MD) · makir@mskcc.org · 646-888-5059
Contact: Principal Investigator (Julia Glade Bender, MD)
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Theodore Laetsch, MD) · CancerTrials@CHOP.EDU · 267-425-5544
Contact: Study coordinator (Meghan Donnelly) · 22DT011@CHOP.EDU · 267-426-9343

Study leads

Theodore Laetsch, MD
Principal Investigator
Children's Hospital of Philadelphia

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

Sarcoma · Sarcoma, Ewing · Desmoplastic Small Round Cell Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boston, United States · Boston, United States

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Refractory Ewing Sarcoma · Relapsed Ewing Sarcoma · Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Palo Alto, United States

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

Neuroblastoma · Rhabdomyosarcoma · Synovial Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gainesville, United States

Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas

Sarcoma · Osteoid Sarcoma · Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China